644 Ocular adverse events associated with programmed death-1 and programmed death ligand-1 immunotherapy by James Murray, Howard Streicher, Elad Sharon, Helen Chen, LeAnne Young, Shanda Finnigan, H Nida Sen

Ocular adverse events in PD-1 and PD-L1 inhibitors by James Murray, Howard Streicher, Elad Sharon, LeAnne Young, Shanda Finnigan, H Nida Sen, Helen X Chen

Get full text

Phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: adrenocortical carcinoma cohort by Howard Streicher, Elad Sharon, Razelle Kurzrock, Young Kwang Chae, Benjamin Tan, Megan Othus, Christine McLeod, Charles Blanke, Helen X Chen, Sandip P Patel, Gabby Lopez, Tridu Huynh, Timothy Kuzel, Christopher W Ryan

Get full text

Phase IB study of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumors by Howard Streicher, Elad Sharon, Mariano Severgnini, Michael Manos, Anita Giobbie-Hurder, F Stephen Hodi, Andrew S Brohl, Philippe L Bedard, Kevin Tyan, Scott Rodig, Osama E Rahma, Daniel J Renouf, Emma Hathaway, Rachel Cunningham

Get full text

45 An integrative immune signature of complementary circulating and tumoral biomarkers maximizes the predictive power of adjuvant immunotherapeutic benefits for high-risk melanoma... by Lisa H Butterfield, Howard Streicher, Patrick Hwu, Walter J Storkus, Ahmad A Tarhini, John M Kirkwood, F Stephen Hodi, Dung-Tsa Chen, Sandra J Lee, Issam El Naqa, William A LaFramboise, Arivarasan D Karunamurthy, Timothy I Shaw, Alyssa Obermayer

Phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the desmoid tumors by Howard Streicher, Elad Sharon, Razelle Kurzrock, Young Kwang Chae, Megan Othus, Sandip Patel, Christine McLeod, Charles Blanke, Benjamin Powers, Chung-Tsen Hsueh, Helen X Chen, Hye Sung Kim, Liam Il-Young Chung, Christopher W Ryan, Rangaswamy Govindarajan, Silvana Bucur

Get full text

Phase II trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors SWOG/NCI experience: invasive mucinous or non-mucinous lepidic adenocarcinoma of the lung (formerly bronchi... by Young Kwang Chae, Megan Othus, Sandip Pravin Patel, David E. Gerber, Tawee Tanvetyanon, Hye Sung Kim, Liam Il-Young Chung, Christine M. McLeod, Gabby Lopez, Helen X. Chen, Elad Sharon, Howard Streicher, Cristopher W. Ryan, Charles D. Blanke, Razelle Kurzrock

Get full text

Improved prognosis and evidence of enhanced immunogenicity in tumor and circulation of high-risk melanoma patients with unknown primary by Lisa H Butterfield, Howard Streicher, Patrick Hwu, Walter J Storkus, Ahmad A Tarhini, John M Kirkwood, F Stephen Hodi, Vernon K Sondak, Jose R Conejo-Garcia, Sandra J Lee, Aik-Choon Tan, Issam M El Naqa, William A LaFramboise, Arivarasan D Karunamurthy

Get full text

A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative anal... by Howard Streicher, Sandra P D'Angelo, Gary K Schwartz, Suzanne George, James L Chen, Cristina R Antonescu, Allison L Richards, Mohammed M Milhem, Nathan D Seligson, Austin C Goodrich, Brian A Van Tine, Jordan D Campbell, David A Liebner, William D Tap

Get full text

Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to ma... by Mariam Saad, Sandra J. Lee, Aik Choon Tan, Issam M. El Naqa, F. Stephen Hodi, Lisa H. Butterfield, William A. LaFramboise, Walter Storkus, Arivarasan D. Karunamurthy, Jose Conejo-Garcia, Patrick Hwu, Howard Streicher, Vernon K. Sondak, John M. Kirkwood, Ahmad A. Tarhini

Get full text

Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in... by Howard Streicher, Elad Sharon, Razelle Kurzrock, Young Kwang Chae, Megan Othus, Edward Mayerson, Melissa Plets, Charles Blanke, Ashish Sangal, Benjamin Powers, Chung-Tsen Hsueh, Rashmi Chugh, Suresh Nair, Mark Agulnik, G Thomas Budd, Michael J Wagner, Sandip P Patel, Chris Ryan, Adrienne I Victor, Kirsten M Leu

Get full text

Immunological biomarkers of response and resistance to treatment with cabozantinib and nivolumab in recurrent endometrial cancer by Ignacio I Wistuba, Howard Streicher, Seunghee Kim-Schulze, Stephanie Lheureux, Sacha Gnjatic, Mayte Suarez-Farinas, Manishkumar Patel, Jianjun Zhang, Cara L Haymaker, Lisa Wang, Gheath Al-Atrash, Edgar Gonzalez-Kozlova, Geoffrey Kelly, Ganiraju Manyam, Vladimir Roudko, Diane Marie Del Valle, Emir Radkevich, Xie Hui, Kevin Tuballes, Swati Atale, Benito CzinCzin, Ryan Thompson

Get full text